Allergy/Asthma News

In this video, Nitin Damle, MD, MS, MACP, past president of the ACP, discusses highlights from his presentation at the virtual ACP Internal Medicine Meeting on the health consequences of climate change.

In adults with moderate to severe asthma, responsiveness to parenteral corticosteroids may be useful to predict lung function decline.

A review of 150 studies yielded “no clear evidence” that patients with asthma are at increased risk for COVID-19 diagnosis, hospitalization, severity or mortality.

Adults with asthma and type 2 diabetes had lower counts of asthma exacerbations and symptoms after initiating treatment with a glucagon-like peptide-1 receptor agonist compared with other drugs for diabetes treatment intensification.

Assessments in the ED can identify patients who are eligible to have a penicillin allergy removed from their electronic health record, according to findings of a pilot study presented virtually at the SHEA Spring Conference.

The FDA has approved a self-injectable formulation of Xolair for appropriate patients with moderate to severe persistent allergic asthma, nasal polyps or chronic idiopathic urticaria, according to the manufacturers.

Researchers reported a significant decline in asthma exacerbations during the COVID-19 pandemic across all age groups, sexes and most regions in England.

Many women receive conflicting information on their diet while breastfeeding children with food allergy, according to research published in the Annals of Allergy, Asthma and Immunology.

In a new study, adherence to asthma biologic therapy was higher than adherence to inhaled corticosteroids among adults with asthma.

About half of the first-year positions that were offered in the 2021 Main Residency Match were in primary care, family medicine, internal medicine and pediatrics, and most of these positions have been filled, according to the National Resident Matching Program.